D’ANGELO, Paolo Fiscal Code DNGPLA59L30G273F
Palermo, Italy, 1959 July 30th
A.R.N.A.S. – Pediatric Hematology and Oncology Unit, Piazza Nicola Leotta n. 4, 90127 Palermo.
Medical doctor in Pediatric Hematology and Oncology since 2001 November 1th
Head of the staff since 2011 September 1th
1988 Febbruary - 1988 October fellowship “L. Marangoni”
Division of Pediatric Hematology, S. Gerardo Hospital, Monza, Italy
1989 April - 1991 March, fellowship “Fondazione Tettamanti”
Division of Pediatric Hematology, S. Gerardo Hospital, Monza, Italy
1991 March 18th - 2001 October 31th
Azienda Ospedaliera “Villa via Fattori 61, Palermo.
Assistant of Pediatric Division from 1991 March 18th to 1993 December 31th
Hospital Aid of Pediatric Division from 1994 Jannuary to 2001 October 31th
2001 November 1th to 2009 March 31th
Azienda ARNAS Civico, Di Cristina e Benfratelli, Palermo. Piazza Nicola Leotta, 4 - 90127 Palermo, Italy.
Medical director of first level – Pediatric Hematology
EDUCATION
1985 November 7th
Faculty of Medicine and Surgery of the University of Palermo, Italy
Degree in Medicine and Surgery
1989 November 15th
Faculty of Medicine and Surgery, University of Palermo, Italy.
Pediatrics
1995 November 9th
Catholic University of the Sacred Hearth – Rome, Italy
Pediatric Hematology and Oncology
RESEARCH INTERESTS
Pediatric Oncology and Hematology. Palliative Care. Rare Tumors.
111
Scopus Publications
Scopus Publications
Diagnostic Delay and Survival in Pediatric Rhabdomyosarcoma: Is Time a Critical Factor? Maria C. Affinita, Stefano Chiaravalli, Giuseppe M. Milano, Ida Russo, Katia Perruccio, Ariana Tagarelli, Patrizia Bertolini, Carla Manzitti, Federico Mercolini, Angela Tamburini, Francesco De Leonardis, Paolo D’Angelo, Stefania Cardellicchio, Andrea Di Cataldo, Daniela Di Pinto, Rosa Maria Mura, Beatrice Coppadoro, Andrea Ferrari, Gianni Bisogno Journal of Pediatric Hematology Oncology, 2026 Background: Timely diagnosis is considered critical in pediatric oncology to optimize treatment outcomes, as delays may impact tumor extension and prognosis. We aimed to assess whether the time to diagnosis and treatment initiation for pediatric patients with rhabdomyosarcoma (RMS) improved over time in Italy and whether longer delays were associated with tumor extension and prognosis. Methods: We analyzed 749 pediatric patients diagnosed with RMS between 1996 and 2016. Diagnostic interval (DI) was defined as the number of days from symptom onset to diagnosis, while treatment interval (TI) was defined as the time from symptom onset to treatment initiation. DI was correlated with tumor characteristics at diagnosis, and TI was analyzed in relation to survival, using Kaplan-Meier analysis. Results: The median DI was 32 days, showing a decreasing trend from 39.5 days in 1996 to 2000 to 30 days in 2011 to 2016. A longer DI was associated with age, unfavorable histology, and metastatic disease in univariate analysis, but these were not confirmed in multivariate analysis. The median TI was 48 days. Five-year event-free survival (EFS) and overall survival (OS) were 59.7% and 69.3%. In multivariate analysis, prognosis was negatively associated with age at diagnosis, unfavorable site, nodal involvement, and metastatic disease. TI was not associated with survival. Conclusions: In our national cohort, the time from symptom onset to diagnosis showed a trend toward shortening in recent years. While a timely diagnosis can provide clarity on the child’s condition and potentially reduce parental anxiety, it does not substantially impact tumor characteristics or patient outcomes.
Metachronous Bilateral Adrenal Neuroblastoma: A Case Report and Literature Review Serena Tropia, Angela Guarina, Giulia Angela Restivo, Fabrizio Di Francesco, Angela Trizzino, Paolo D’Angelo Journal of Pediatric Hematology Oncology, 2024 A baby presented with a large right adrenal mass, multiple hepatic lesions and diffuse bone marrow infiltration when she was just over 1 month old. After needle biopsy and a histologic definition of neuroblastoma, she underwent chemotherapy and a subsequent complete resection. Three years after diagnosis, a large left adrenal localized mass was detected. The patient underwent complete surgical excision, and a diagnosis of poorly differentiated neuroblastoma with multiple lymph nodes involvement was defined. Adjuvant chemotherapy was initiated. To our knowledge, it is the first case report of metachronous bilateral adrenal neuroblastomas harboring completely different genetic expression profiles.
Role of 18F-Fluorodeoxyglucose Positron Emission Tomography in Children With Germ Cell Tumor After Chemotherapy Maria Debora De Pasquale, Paolo D’Angelo, Alessandro Crocoli, Stefano G. Vallero, Patrizia Bertolini, Evelina Miele, Monica Terenziani Journal of Pediatric Hematology Oncology, 2024 Background/Aim: 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) is a diagnostic tool widely used in adult oncology and some pediatric oncological settings. There are no established recommendations for the use of this imaging modality in pediatric malignant germ cell tumors (mGCT), however. Our aim is to evaluate the role of 18F-FDG PET/CT in the restaging of mGCT after chemotherapy in children and adolescents. Methods: We retrospectively reviewed patients with mGCT treated in Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) centers who underwent 18F-FDG PET/CT between 2011 and 2021. Results: Seventeen patients (median age 13 y) were included in the study. In 14 patients, 18F-FDG PET/CT was performed at diagnosis; 12 showed pathologic uptake. The 2 18F-FDG PET/CT negative cases were histologically defined as yolk sac tumor (YST) and mixed (chorioncarcinoma, YST). Nine of the 12 patients who had pathologic 18F-FDG PET/CT at diagnosis repeated the examination after neoadjuvant chemotherapy, before, second look surgery. In 5 cases, no pathologic uptake was evident. Histology showed necrosis alone in 4 cases and necrosis and mature teratoma in 1. In 3 of the 6 cases with pathologic uptake (2 of 6 patients did not perform the examination at diagnosis), histology showed persistence of malignant component, whereas in the remaining 3 cases, necrosis and mature teratoma were present. Conclusion: In our review of a series of children with mGCT, 18F-FDG PET/CT after neoadjuvant chemotherapy showed 1 of 5 false negatives and was unable to discriminate between residual malignant component and mature teratoma.
Should we reduce routine surveillance imaging in pediatric germ cell tumors? Monica Terenziani, Francesco Barretta, Giovanna Gattuso, Gianni Bisogno, Massimo Conte, Alessandro Crocoli, Maria Debora De Pasquale, Davide Biasoni, Filippo Spreafico, Paolo D'Angelo Pediatric Blood and Cancer, 2023 This paper retrospectively investigated the site and the detection method of relapses in children and adolescents with malignant germ cell tumors enrolled in the TCGM‐AIEOP‐2004 Study and subsequently developed a relapse, in order to evaluate a possible reduction in radiological exposure during follow‐up. Including all malignant cases, serum tumor markers identified a relapse in more than 70% and, according to the selection criteria published by Children Oncology Group in 2018, in more than 90% of cases. These results confirm the importance of serum tumor markers as a relapse detection method, with possible reduction of radiology exams in specific subgroups.
Role of centers with different patient volumes in the management of rhabdomyosarcoma. An analysis by the Italian Pediatric Soft Tissue Sarcoma Committee Gianni Bisogno, Giovanna Congiu, Maria Carmen Affinita, Giuseppe Maria Milano, Ilaria Zanetti, Beatrice Coppadoro, Carla Manzitti, Eleonora Basso, Angela Tamburini, Fraia Melchionda, Monica Cellini, Roberta Pericoli, Paolo D'Angelo, Andrea Di Cataldo, Francesco De Leonardis, Marco Rabusin, Federica De Corti, Angelica Zin, Rita Alaggio, Giovanni Scarzello, Andrea Ferrari Pediatric Blood and Cancer, 2021 The survival of children with rhabdomyosarcoma (RMS) has gradually improved as a result of the adoption of multidisciplinary treatments. Dedicated skills and facilities are indispensable and more readily available at reference centers. In this study, we examined the role of centers’ experience (based on the number of patients treated) in their management of patients with RMS.
Rasburicase-induced Methemoglobinemia: A Case Report and Literature Review Ilaria Pirrone, Piero Farruggia, Francesca Cacciatore, Antonino Giambona, Angela Guarina, Anna Paola Marcello, Clara Mosa, Simona Scalzo, Paolo D’Angelo Journal of Pediatric Hematology Oncology, 2021 Rasburicase is a recombinant urate oxidase enzyme indicated for tumor lysis syndrome, a potential life-threatening oncologic emergency that occurs most commonly during initial chemotherapy for hematological malignancies. As a result of the defects in the physiological antioxidant pathway, erythrocytes of patients with glucose-6-phosphate dehydrogenase deficiency are not protected against the oxidizing stress exerted by hydrogen peroxide generated with the administration of rasburicase. The authors report a 14-year-old patient, diagnosed with T-cell acute lymphoblastic leukemia, who developed methemoglobinemia and hemolytic anemia with low oxygen saturation after starting steroids, hyperhydratation, and rasburicase administration. The complications resolved with supportive therapy only.
Extra-appendicular neuroendocrine tumors: A report from the TREP project (2000-2020) Calogero Virgone, Andrea Ferrari, Stefano Chiaravalli, Maria Debora De Pasquale, Alessandro Inserra, Paolo D'Angelo, Martina Funmilayo Ogunleye, Alessandro Crocoli, Stefano Vallero, Simone Cesaro, Rita Alaggio, Gianni Bisogno, Patrizia Dall'Igna Pediatric Blood and Cancer, 2021 Extra‐appendicular neuroendocrine tumors (NETs) are very rare tumors. While diagnostic and therapeutic guidelines are well established for adults, data on children and adolescents are lacking.
Malignant sacrococcygeal germ cell tumors in childhood: The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) experience Paolo D'Angelo, Maria Debora De Pasquale, Francesco Barretta, Maria Carmen Affinita, Massimo Conte, Patrizia Dall'Igna, Andrea Di Cataldo, Alessandro Inserra, Massimo Provenzi, Lucia Quaglietta, Giovanna Riccipetitoni, Filippo Spreafico, Angela Trizzino, Monica Terenziani, and Pediatric Blood and Cancer, 2021 To evaluate clinical features at diagnosis, prognostic factors, and outcomes of malignant sacrococcygeal germ cell tumors (SC‐GCTs) in patients enrolled in the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) TCG 2004 protocol.
Pheochromocytomas and paragangliomas in children: Data from the Italian Cooperative Study (TREP) Calogero Virgone, Marina Andreetta, Stefano Avanzini, Stefano Chiaravalli, Maria Debora De Pasquale, Alessandro Crocoli, Alessandro Inserra, Paolo D'Angelo, Rita Alaggio, Giuseppe Opocher, Giovanni Cecchetto, Andrea Ferrari, Gianni Bisogno, Patrizia Dall'Igna Pediatric Blood and Cancer, 2020 Pheochromocytomas (PCs) are neuroendocrine tumors arising from the chromaffin cells of the adrenal gland, and paragangliomas (PGLs) are their extra‐adrenal counterparts arising from ganglia along the sympathetic/parasympathetic chain. Surgery is the cornerstone of treatment. A sporatic or inherited germline mutation is commonly associated.
Late mortality and causes of death among 5-year survivors of childhood cancer diagnosed in the period 1960–1999 and registered in the Italian Off-Therapy Registry Francesca Bagnasco, Silvia Caruso, Anita Andreano, Maria Grazia Valsecchi, Momcilo Jankovic, Andrea Biondi, Lucia Miligi, Claudia Casella, Monica Terenziani, Maura Massimino, Carlotta Sacerdote, Vera Morsellino, Giovanni Erminio, Alberto Garaventa, Maura Faraci, Concetta Micalizzi, Maria Luisa Garrè, Marta Pillon, Giuseppe Basso, Eleonora Biasin, Franca Fagioli, Roberto Rondelli, Andrea Pession, Franco Locatelli, Nicola Santoro, Paolo Indolfi, Giovanna Palumbo, Giovanna Russo, Federico Verzegnassi, Claudio Favre, Marco Zecca, Rossella Mura, Paolo D'Angelo, Carmen Cano, Julianne Byrne, Riccardo Haupt, Julianne Byrne, Riccardo Haupt, Paolo Pierani, Nicola Santoro, Andreea Pession, Fulvio Porta, Rossella Mura, Giovanna Russo, Caterina Consarino, Roberta Burnelli, Claudio Favre, Maria Luisa Garrè, Fausto Fedeli, Maura Massimino, Maura Massimino, Monica Cellini, Andrea Biondi, Fiorina Casale, Giuseppe Menna, Giuseppe Basso, Paolo D'Angelo, Patrizia Bertolini, Marco Zecca, Maurizio Caniglia, Valerio Cecinati, Gabriella Casazza, Roberto Foà, Anna Clerico, Franco Locatelli, Saverio Ladogana, Daniela Galimberti, Franca Fagioli, Marco Rabusin, Luigi Nespoli, Simone Cesaro European Journal of Cancer, 2019
Stage 4 s neuroblastoma: Features, management and outcome of 268 cases from the Italian Neuroblastoma Registry Bruno De Bernardi, Andrea Di Cataldo, Alberto Garaventa, Paolo Massirio, Elisabetta Viscardi, Marta Giorgia Podda, Aurora Castellano, Paolo D’Angelo, Elisa Tirtei, Fraia Melchionda, Simona Vetrella, Francesco De Leonardis, Carmelita D’Ippolito, Annalisa Tondo, Antonella Nonnis, Giovanni Erminio, Anna Rita Gigliotti, Katia Mazzocco, Riccardo Haupt Italian Journal of Pediatrics, 2019
Genetic and epigenetic analyses guided by high resolution whole-genome SNP array reveals a possible role of CHEK2 in Wilms tumour susceptibility Oncotarget, 2018
Gastrointestinal tract carcinoma in pediatric and adolescent age: The Italian TREP project experience Alice Indini, Gianni Bisogno, Giovanni Cecchetto, Marco Vitellaro, Stefano Signoroni, Maura Massimino, Giovanna Riccipetitoni, Marco Zecca, Patrizia Dall'Igna, Maria Debora De Pasquale, Alessandro Inserra, Stefano Chiaravalli, Eleonora Basso, Calogero Virgone, Silvia Sorbara, Maria Di Bartolomeo, Paolo D'Angelo, Andrea Ferrari Pediatric Blood and Cancer, 2017
Results of the Third AIEOP Cooperative Protocol on Wilms Tumor (TW2003) and Related Considerations Filippo Spreafico, Davide Biasoni, Salvatore Lo Vullo, Lorenza Gandola, Paolo D’Angelo, Monica Terenziani, Maurizio Bianchi, Massimo Provenzi, Paolo Indolfi, Andrea Pession, Marilina Nantron, Andrea Di Cataldo, Carlo Morosi, Daniela Perotti, Serena Catania, Franca Fossati Bellani, Paola Collini, and Journal of Urology, 2017
Perioperative management of hypertensive neuroblastoma: A study from the Italian Group of Pediatric Surgical Oncologists (GICOP) Luca Pio, Stefano Avanzini, Girolamo Mattioli, Giuseppe Martucciello, Angela Rita Sementa, Massimo Conte, Annarita Gigliotti, Claudio Granata, Ernesto Leva, Anna Maria Fagnani, Umberto Caccioppoli, Nino Tedesco, Jurgen Schleef, Elisa Tirtei, Fortunato Siracusa, Paolo D'Angelo, Pierluigi Lelli Chiesa, Lucia Miglionico, Bruno Noccioli, Elisa Severi, Claudio Carlini, Francesco Vaccarella, Francesco Camoglio, Simone Cesaro, Alessandra Narciso, Giovanna Riccipetitoni, Giovanni Cecchetto, Alessandro Inserra Journal of Pediatric Surgery, 2017
Spiritual support for adolescent cancer patients: A survey of pediatric oncology centers in Italy and Spain Tullio Proserpio, Laura Veneroni, Matteo Silva, Alvaro Lassaletta, Rosalia Lorenzo, Chiara Magni, Marina Bertolotti, Elena Barisone, Maurizio Mascarin, Momcilo Jankovic, Paolo D'Angelo, Carlo A. Clerici, Carmen Garrido-Colino, Ignacio Gutierrez-Carrasco, Aizpea Echebarria, Andrea Biondi, Maura Massimino, Fiorina Casale, Angela Tamburini, Andrea Ferrari Tumori, 2016
Bone Sarcomas in Children and Adolescents Floriana Di Marco, Fabrizia Ferraro, Clara Mosa, Angela Trizzino, Serena Tropia, Paolo D'Angelo Journal of Pediatric Biochemistry, 2015
Genetic abnormalities in adolescents and young adults with neuroblastoma: A report from the Italian Neuroblastoma group Katia Mazzocco, Raffaella Defferrari, Angela Rita Sementa, Alberto Garaventa, Luca Longo, Marilena De Mariano, Maria Rosaria Esposito, Francesca Negri, Davide Ircolò, Elisabetta Viscardi, Roberto Luksch, Paolo D'Angelo, Arcangelo Prete, Aurora Castellano, Paolo Massirio, Giovanni Erminio, Anna Rita Gigliotti, Gian Paolo Tonini, Massimo Conte Pediatric Blood and Cancer, 2015
Long-term results of the AIEOP LNH-97 protocol for childhood lymphoblastic lymphoma Marta Pillon, Maurizio Aricò, Lara Mussolin, Elisa Carraro, Valentino Conter, Alessandra Sala, Salvatore Buffardi, Alberto Garaventa, Paolo D'Angelo, Luca Lo Nigro, Nicola Santoro, Matilde Piglione, Alessandra Lombardi, Fulvio Porta, Simone Cesaro, Maria L. Moleti, Fiorina Casale, Rossella Mura, Emanuele S. G. d'Amore, Giuseppe Basso, Angelo Rosolen Pediatric Blood and Cancer, 2015
Mature and immature teratoma: A report from the second Italian pediatric study Monica Terenziani, Paolo D'Angelo, Alessandro Inserra, Renata Boldrini, Gianni Bisogno, Gian Luca Babbo, Massimo Conte, Patrizia Dall' Igna, Maria Debora De Pasquale, Paolo Indolfi, Luigi Piva, Giovanna Riccipetitoni, Fortunato Siracusa, Filippo Spreafico, Paolo Tamaro, Giovanni Cecchetto Pediatric Blood and Cancer, 2015
MPL W515L mutation in pediatric essential thrombocythemia Piero Farruggia, Paolo D'Angelo, Maria La Rosa, Nunzia Scibetta, Giuseppe Santangelo, Antonio Lo Bello, Elena Duner, Maria Luigia Randi, Maria Caterina Putti, Alessandra Santoro Pediatric Blood and Cancer, 2013
Synchronous bilateral Wilms tumor: A report from the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) Paolo Indolfi, Alessandro Jenkner, Monica Terenziani, Alessandro Crocoli, Annalisa Serra, Paola Collini, Davide Biasoni, Lorenza Gandola, Gianni Bisogno, Giovanni Cecchetto, Martina Di Martino, Paolo D'Angelo, Maurizio Bianchi, Massimo Conte, Alessandro Inserra, Andrea Pession, Filippo Spreafico, on behalf of the AIEOP Wilms Tumor Working Group Cancer, 2013
Genomic profiling by whole-genome single nucleotide polymorphism arrays in Wilms tumor and association with relapse Daniela Perotti, Filippo Spreafico, Federica Torri, Beatrice Gamba, Pio D'Adamo, Sara Pizzamiglio, Monica Terenziani, Serena Catania, Paola Collini, Marilina Nantron, Andrea Pession, Maurizio Bianchi, Paolo Indolfi, Paolo D'Angelo, Franca Fossati‐Bellani, Paolo Verderio, Fabio Macciardi, Paolo Radice, on behalf of the Associazione Italiana Ematologia Oncologia Pediatrica Wilms Tumor Working Group Genes Chromosomes and Cancer, 2012
Improved survival of children with neuroblastoma between 1979 and 2005: A report of the Italian neuroblastoma registry Riccardo Haupt, Alberto Garaventa, Claudio Gambini, Stefano Parodi, Giuliana Cangemi, Fiorina Casale, Elisabetta Viscardi, Maurizio Bianchi, Arcangelo Prete, Alessandro Jenkner, Roberto Luksch, Andrea Di Cataldo, Claudio Favre, Paolo D'Angelo, Giulio Andrea Zanazzo, Giampaolo Arcamone, Gian Carlo Izzi, Anna Rita Gigliotti, Guido Pastore, Bruno De Bernardi Journal of Clinical Oncology, 2010
Pancreatic tumors in children and adolescents: The Italian TREP project experience Patrizia Dall'Igna, Giovanni Cecchetto, Gianni Bisogno, Massimo Conte, Pierluigi Lelli Chiesa, Paolo D'Angelo, Francesco De Leonardis, Gianluca De Salvo, Francesca Favini, Andrea Ferrari, on Behalf of the TREP Group Pediatric Blood and Cancer, 2010
Synovial sarcoma of children and adolescents: The prognostic role of axial sites Andrea Ferrari, Gianni Bisogno, Rita Alaggio, Giovanni Cecchetto, Paola Collini, Angelo Rosolen, Cristina Meazza, Paolo Indolfi, Alberto Garaventa, Luigi De Sio, Paolo D’Angelo, Paolo Tamaro, Michela Casanova, Modesto Carli European Journal of Cancer, 2008
Mature and immature teratomas: Results of the first paediatric Italian study Margherita Lo Curto, Paolo D’Angelo, Giovanni Cecchetto, Catherine Klersy, Patrizia Dall’Igna, Antonia Federico, Fortunato Siracusa, Rita Alaggio, Gabriella Bernini, Massimo Conte, Tina De Laurentis, Andrea Di Cataldo, Alessandro Inserra, Nicola Santoro, Paolo Tamaro, Paolo Indolfi Pediatric Surgery International, 2007
Pleuropulmonary blastoma: A differential diagnosis of chronic cough. Long-term survival after multimodal aggressive therapy Italian Journal of Pediatrics, 2006
Neuroblastoma in the first year of life. The Italian contribution to a study of the Internation Society of Paediatric Oncology Europe Neuroblastoma Group Italian Journal of Pediatrics, 2006
Cardiac and pulmonary function abnormalities in thalassemia major patients Cardiovascular Imaging, 1998
Zinc deficiency and cell-mediated and humoral autoimmunity of insulin- dependent diabetes in thalassemic subjects Journal of Pediatric Endocrinology and Metabolism, 1998
The heart in β-thalassemia major patients. An MR study Radiologia Medica, 1998
Serum and fecal pancreatic enzymes in beta-thalassemia major Giuseppe Montalto, Paolo D’Angelo, Antonio Lo Casto, Antonio Carroccio, Maurizio Soresi, Massimo Midiri, Roberto Malizia, Vincenza Scafidi International Journal of Pancreatology, 1997
High-dose cytosine arabinoside and fractionated total body irradiation as a preparative regimen for the treatment of children with acute lymphoblastic leukemia and Down syndrome by allogeneic bone marrow transplantation Bone Marrow Transplantation, 1996
Leukemic ophthalmopathy in children: Results of a polycentric study in 59 cases Haematologica, 1994
Thyroid disease in patients with thalassemia Haematologica, 1994
Leukemic ophthalmopathy: A report of 21 pediatric cases M. Lo Curto, P. D'Angelo, F. Lumia, G. Provenzano, A. Zingone, C. Bachelot, S. Bagnulo, H. Behrendt, M. Jankovic, G. Masera, J. Mann, P. Rosito, G. Schaison, D. Schuler Medical and Pediatric Oncology, 1994
Acute lymphoblastic leukaemia in a child with cystic fibrosis Haematologica, 1992
Central venous catheter-related complications after bone marrow transplantation in children with hematological malignancies Bone Marrow Transplantation, 1992
Thiamine responsive megaloblastic anemia: A ten-years therapy follow-up Haematologica, 1989
Height of children off therapy after acute lymphoblastic leukemia Maria Grazia Zurlo, Elisabetta Senesi, Benedetto Terracini, Donato Balducci, PierfranCo Biddau, Paolo D'Angelo, Domenico Rosati, Stefano GanduS, Enrico Madon, Antonia Mancini, Luigi Nespoli, Gabriella Piacentini, Sultana Razon Veronesi, Paolo Tamaro Pediatric Hematology and Oncology, 1988
RESEARCH OUTPUTS (PATENTS, SOFTWARE, PUBLICATIONS, PRODUCTS)
Coordinator of Italian Protocol for Germ Cell Tumors
Industry, Institute, or Organisation Collaboration
A.R.N.A.S. Civico, Di Cristina e Benfratelli Hospitals